Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug 10:13:573-580.
doi: 10.2147/RRU.S268569. eCollection 2021.

Minimal Invasive Treatment in Pelvic-Ureteric Junction Obstruction: A Comprehensive Review

Affiliations
Review

Minimal Invasive Treatment in Pelvic-Ureteric Junction Obstruction: A Comprehensive Review

Irfan Wahyudi et al. Res Rep Urol. .

Abstract

Pelvic-ureteric junction obstruction (PUJO) is a common condition, and one of the lead causes of hydronephrosis in children. Currently, the gold standard treatment of PUJO is open surgery using the Anderson-Hynes-modified dismembered pyeloplasty technique. However, with the advancement of medical technology, several minimal invasive approaches were developed, including endoscopic, laparoscopic, and robotic approach, from which the best choice of surgical technique was yet to be determined. Considering the advantages and disadvantages of these methods, the recommended option is to tailor the best surgical approach to each individual patient, and to the surgeons' preference and experience. Considering these recent advances, a new algorithm is proposed to choose the best minimal invasive modalities invasive treatment to treat PUJO.

Keywords: Anderson–Hynes dismembered pyeloplasty; PUJO; hydronephrosis; minimal invasive.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest to disclose.

Figures

Figure 1
Figure 1
Historical development of pelvic-ureteric junction obstruction treatment.
Figure 2
Figure 2
Recommended algorithm in pelvic-ureteric junction minimal invasive management.

References

    1. Termos S, AlKabbani M, Ulinski T, et al. Ureteropelvic junction obstruction and parathyroid adenoma: coincidence or link? Case Reports Nephrol. 2017;2017:1–4. doi:10.1155/2017/9852912 - DOI - PMC - PubMed
    1. Radmayr C, Bogaert G, Dogan HS, et al. EAU Guidelines on Paediatric Urology. The Netherlands: EAU Guidelines Office; 2020.
    1. Jackson L, Woodward M, Coward RJ. The molecular biology of pelvi-ureteric junction obstruction. Pediatr Nephrol. 2018;33(4):553–571. doi:10.1007/s00467-017-3629-0 - DOI - PMC - PubMed
    1. Grasso M, Caruso RP, Phillips CK. UPJ obstruction in the adult population: are crossing vessels significant? Rev Urol. 2001;3(1):42–51. - PMC - PubMed
    1. Avanoglu A, Tiryaki S. Embryology and morphological (Mal) development of UPJ. Front Pediatr. 2020;8:7–9. doi:10.3389/fped.2020.00137 - DOI - PMC - PubMed

LinkOut - more resources